Abstract

Sialoadhesin and CD22 are members of a recently characterized family of sialic acid-dependent adhesion molecules belonging to the immunoglobulin superfamily. Sialoadhesin is a macrophage-restricted receptor containing 17 extracellular Ig-like domains which recognizes oligosaccharides terminating in NeuAc alpha 2-3Gal in N- and O-linked glycans. CD22 is a B cell-restricted receptor with seven Ig-like domains which selectively recognizes oligosaccharides terminating in NeuAc alpha 2-6Gal in N-glycans. Sequence similarity between these proteins is highest within their first four amino-terminal Ig-like domains. Here we identify the domain(s) containing the binding sites of both molecules by generating a series of extracellular domain deletion mutants fused to the Fc portion of human IgG1. Binding activity was analyzed by solid phase cell adhesion assays and also by surface plasmon resonance using purified glycophorin and CD45 as ligands for sialoadhesin and CD22, respectively. For sialoadhesin, the amino-terminal V-set Ig-like domain was both necessary and sufficient to mediate sialic acid-dependent adhesion of the correct specificity. In contrast, for murine CD22, only constructs containing both the V-set domain and the adjacent C2-set domain were able to mediate sialic acid-dependent binding. These results are consistent with the sialic acid binding site for both proteins residing in the membrane distal V-set domain, but for CD22 a direct contribution in binding from the neighboring C2-set domain cannot be excluded.

Highlights

  • Sialoadhesin and CD22 are members of a recently characterized family of sialic acid-dependent adhesion molecules belonging to the immunoglobulin superfamily

  • Sialoadhesin is expressed by macrophages in hemopoietic and secondary lymphoid tissues, myelin- associated glycoprotein (MAG) is present on myelinating oligodendrocytes and Schwann cells, CD33 is found on myeloid cells and CD22 is B cell-restricted

  • We have extended this analysis and shown that taining the first domain of sialoadhesin fused to the Fc portion of human IgG1; Sn(d1–3L)Fc, sialoadhesin-immunoglobulin chimera containing domains 1ϩ2ϩ3 of sialoadhesin fused to the Fc portion of human IgG1 and expressed with the leader peptide of CD33; Sn(d1), a soluble form of sialoadhesin consisting of the isolated V-set domain; PCR, polymerase chain reaction; PBS, phosphate-buffered saline; BSA, bovine serum albumin; NCAM, neural cell adhesion molecule; ICAM, intercellular adhesion molecule

Read more

Summary

Introduction

Sialoadhesin and CD22 are members of a recently characterized family of sialic acid-dependent adhesion molecules belonging to the immunoglobulin superfamily. The amino-terminal V-set Ig-like domain was both necessary and sufficient to mediate sialic acid-dependent adhesion of the correct specificity. Previous studies using truncation mutants fused to the Fc portion of human IgG1 have shown that the first three Ig-like domains of sialoadhesin and CD22 are sufficient for mediating sialic aciddependent binding to a variety of cells [3, 4, 6, 13, 17, 23, 24].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call